Trials Define Anti-Tumor Effects of Anti-Resorptive Agents†: Denosumab Ahead of Zoledronate 2 to 1

Author： Weintraub Ben  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.2, 2011-04, pp. : 135-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare

By Murdaca Giuseppe  

American Journal of Clinical Dermatology, Vol. 11, Iss. 6, 2010-12 ,pp. : 437-439

Adis International

Access to resources Recommend Favorite

The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease

By Reguiaï Ziad   Grange Florent  

American Journal of Clinical Dermatology, Vol. 8, Iss. 2, 2007-01 ,pp. : 67-77

Adis International

Access to resources Recommend Favorite

The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors

By Bernt K.M.   Ni S.   Li Z.-Y.   Shayakhmetov D.M.   Lieber A.  

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 746-755

Elsevier

Access to resources Recommend Favorite

New anti-epileptic drugs: overcoming the limits of randomised controlled trials

By Brigo Francesco  

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 440-443

Blackwell Publishing

Access to resources Recommend Favorite

Novel Pharmacological Activity of Artesunate and Artemisinin: Their Potential as Anti-Tubercular Agents

By Choi Won Hyung  

Journal of Clinical Medicine, Vol. 6, Iss. 3, 2017-03 ,pp. : 30-30

MDPI

Access to resources Recommend Favorite